Sageworth Trust Company of South Dakota’s Amedisys AMED Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-59	Closed	-$4.34K	–	46
2023 Q1	$4.34K	Hold	59	–	–	0.01%	154
2022 Q4	$5K	Hold	59	–	–	0.01%	152
2022 Q3	$6K	Sell	59 -103	-64%	-$12.3K	0.01%	131
2022 Q2	$17K	Sell	162 -14	-8%	-$1.79K	0.04%	94
2022 Q1	$30K	Sell	176 -404	-70%	-$60.4K	0.06%	84
2021 Q4	$94K	Buy	+580	New	+$93.2K	0.14%	61

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Sageworth Trust Company of South Dakota's AMED Position: Q2 2023 in Review

Sageworth Trust Company of South Dakota sold out of Amedisys (AMED) in Q2 2023, closing a stake of 59 shares — an estimated $4.34K sold.

Sageworth Trust Company of South Dakota first reported a position in AMED in Q4 2021 and held it in 6 quarters. The position peaked at $94K in Q4 2021. 300 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

Sageworth Trust Company of South Dakota reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
Sageworth Trust Company of South Dakota sold 59 Amedisys shares in Q2 2023, an estimated $4.34K.
Sageworth Trust Company of South Dakota first reported a position in Amedisys in Q4 2021 and held it in 6 quarters.
Sageworth Trust Company of South Dakota's Amedisys position peaked at $94K in Q4 2021.
300 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q2 2023, filed 3 Aug 2023.